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Summary 
Lipopolysaccharide (LPS) activation of ceUs of monocytic lineage leads to rapid and transient 
expression of a set of inflammatory gene products, including tissue factor (TF). This transmembrane 
receptor is the major cellular initiator of the blood coagulation cascades, and induced expression 
of TF is postulated to play a role in inflammation. Functional studies using transfected THP-1 
monocytic cells revealed the presence of a 56-bp LPS response element (LRE) within the TF 
promoter that conferred LPS responsiveness to a heterologous promoter. LPS stimulation of these 
cells activated proteins that bound to nucleotide sequences within the LRE resembling consensus 
binding sites for activator protein 1 (AP-1) and nuclear factor KB (NF-KB). Induction of the 
TF gene may represent a prototypic example of gene activation in monocytic cells by assembly 
of transcription factor complexes, and may clarify the role of AP-1 and NF-gB in the regulation 
of other LPS-responsive genes. 
B 
acterial endotoxin (LPS) is responsible  for many of the 
cellular responses to Gram-negative bacterial infections 
in higher primates. These responses may be induced after the 
association of LPS with the plasma protein LBP (LPS  binding 
protein) and the binding of this complex to the cell surface 
receptor CD14 (1, 2). LPS stimulates cells of monocytic lin- 
eage to rapidly and transiently express a defined set of gene 
products, including TNF (3), I1.-6 (4), II,1 (5), and the trans- 
membrane Frotein tissue factor (TF)  1 (6). It is suspected that 
common pathways may exist in these cells to coordinate tran- 
scriptional activation during inflammation. Induced expres- 
sion of both the TF receptor and TNF have been shown to 
be mediators of fatal bacteremic shock (7-9), indicating that 
antibodies against these molecules may offer a potential therapy 
to life-threatening infection. 
TF is the receptor and cofactor for plasma factors VII/VIIa, 
and mediates the cellular initiation of the coagulation serine 
protease cascades (10, 11). Thus, TF is also responsible for 
thrombin generation and the associated inflammatory conse- 
quences via the thrombin receptor (12). In addition, expres- 
sion of TF by monocytic cells has been postulated to play 
a role in inflammation (13) and the cellular immune response 
1Abbreviations  used  in  this  paper:  AP-1, activator  protein  1;  CAT, 
chloramphenicol acetyl transferase; EMSA, dectrophoretic  mobility shift 
assay; LRE, LPS response element; NF-xB, nuclear factor xB; TF, tissue 
factor. 
(14, 15). Antigen-specific CD4 T cells induce TF expression 
in monocytes and macrophages by cell-cell interaction as well 
as by lymphokine collaboration (16-18). Pathologic activation 
of the coagulation cascades by TF within the vasculature has 
been implicated in several  disease states, including septic shock, 
disseminated intravascular  coagulation, and various  throm- 
boembolic disorders  (9,  13,  19). 
In this study, we attempted to identify DNA sequence ele- 
ments and their corresponding transcription factors that are 
required for LPS-mediated induction of the TF promoter in 
THP-1 monocytic cells. We found that a 56-bp regulatory 
region was required, which we have designated an LPS re- 
sponse element (LRE). Moreover, exposure of these cells to 
LPS activated two distinct proteins that bound to nucleotide 
sequences within the LRE that resemble consensus binding 
sites for both activator protein 1 (AP-1) (20) and nuclear factor 
KB  (NF-KB) (21). We  propose that engagement of these 
binding sites is required to mediate the pattern of transcrip- 
tional induction of the TF promoter observed for cells of 
monocytic lineage. 
Materiab  and Methods 
Plasmids.  The promoterless  ludferase  reporter vectors  p19LUC 
(22), pRSVLUC (23), and pRSVCAT (24) were used as con- 
trois in the transfections. The construction of pTF(-2106)LUC, 
pTF(-948)LUC, pTF(-383)LUC,  pTF(-278)LUC, pTF(-111)LUC, 
pTF(-21)LUC,  pTFM2(-278)LUC,  pTFM3(-278)LUC,  and 
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of the TF promoter was achieved by Exonuclease III (Promega Bio- 
tee., Madison,  WI) digestion ofa 504-bp fragment (-383 to +121) 
in pGEM3Zf(-) and subsequent insertion of  DNA fragments into 
p19LUC (Fig. 1). pPAI-LUC (Fig. 2) was made by inserting a 106-bp 
DNA fragment, containing the minimal promoter from the human 
plasminogen activator inhibitor type 1 (PAI-1) gene (-31 to + 75 
[22]),  upstream of the luciferase reporter gene in p19LUC. This 
fragment was kindly provided by Drs. M. K~ton and D. Loskutoff. 
Various DNA fragments or double-stranded oligonucleotides from 
the TF promoter (Table 2) were inserted upstream of this minimal 
promoter in pPAI-LUC (Fig. 2). pTFM5(-278)LUC and pTFM6- 
(- 278)LUC were made by site-directed mutagenesis of a template, 
pTF(-278)LUC (Fig.  1), using oligonucleotides M17 and M18, 
respectively (Table 2). pTFM7(- 278)LUC and pTFMS(- 278)LUC 
were made in a similar way but used a temphte, pTFM4(- 278)LUC, 
which contains mutations in both AP-1 sites (Fig.  3). 
Nuclear Extracts and Electrophoretic  Mobility Shift Assay (EMSA). 
Nuclear extracts were prepared as described previously (26) either 
from control THP-1 cells or from cells stimulated with 10/zg/ml 
of LPS Escherichia coli 0111:B4 (Calbiochem Behring Corp., San 
Diego, CA) for 45 rain. EMSAs were performed using a modifica- 
tion of the protocol described previously (27). Extracts were in- 
cubated on ice for 30 min with 6/~g of poly (dI.dC) (Pharmacia 
Fine Chemicals, Uppsah, Sweden) in 18/~1 of  buffer (25 mM Hepes, 
pH 7.9; 40 mM KC1; 5 mM MgCh; 0.125 mM EDTA; 0.75 mM 
DT2~ 7.5% glycerol). Next, 0.1-0.5 ng (10,000-50,000 cpm) of 
oligonudentide probe was added and incubation continued for a 
further 15 min on ice and 15 rain at 25~  Ollgonucleotides were 
labded with [~:P]ATP (Amersham Corp., Arlington Heights, IL) 
using either the Klenow fragment of E. coli DNA polymerase I 
or T+ polynucleotide kinase (Boehringer-Mannheim Biochemicals, 
Indianapolis,  IN). Samples were subjected to electrophoresis on a 
6% polyacryhmide gel containing 45 mM Tris-borate, 45 mM boric 
acid,  and 1 mM EDTA. 
Cell Culture.  The human monocytic leukemia cell line, THP-1, 
was obtained from the American Type Culture Collection (Rock- 
viUe, MD) (No. TIB 202).  For this study we used a subline  of 
THP-1, kindly provided by Dr. D. Dialynas, which exhibited low 
levels of TF activity under standard culture conditions and could 
be induced to express high levels of TF activity in response to LPS. 
These cells were cultivated at a density of 2-4  x  10  s ceUs/ml in 
RPMI  1640 supplemented with 20 mM Hepes (adjusted  to pH 
7.4 with NaOH), 50/zM 2-ME, 2 mM t-glutamine, and 7% FCS. 
DNA Transfection  and LPS Induction of the Cloned TF Promo~  A 
DEAE-Dextran transfection procedure was  used (28).  Briefly, 2 
x  10  ? cells were harvested and incubated for 15 rain at 37~  in 
1 ml of STBS (25  mM Tris/C1,  pH  7.4;  5 mM KC1; 0.7 mM 
CaC12; 137 mM NaCh; 0.6 mM Na2HPO4; 0.5 mM MgCh) con- 
taining 4/~g of plasmid DNA and 150 #g/mI of DEAE-Dextran 
(Pharmacia  Fine Chemicals). 2/~g of pRSVCAT was used as an 
internal  control  in  the  transfections.  Ceils  were  washed  and 
resuspended in complete media and cultivated for 46 h.  At this 
time, each transfection was divided into two equal portions which 
were incubated at 37~  for a further 5 h either in the presence 
or absence of 10/~g/ml LPS. Cells were harvested and hciferase 
activity was  determined. 
Activity Assays.  One-half (50 #1) of the cell lysate (100 #1) from 
transfected THP-1 ceils was assayed for luciferase activity using a 
Monolight 2010 (Analytical Luminescence Laboratory, San Diego, 
CA) as described previously (23).  Chloramphenicol acetyl trans- 
ferase (CAT) activity was determined from 25/~1 of the extract 
using a diffusion-based  assay as described previously (29). 
Results 
LPS Induction of the Human TF Promoter,  A  series of TF 
promoter plasmids was constructed by inserting DNA frag- 
ments,  containing sequential 5' truncations of the TF pro- 
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Figure 1.  LPS induction of TF promoter plasmids from the 5' deletion series. The 5' boundaries of 16 plasmids containing various truncations of 
the TF promoter are shown. Some key restriction endonudease sites are indicated. The positions of the TATA  consensus promoter element, AP-1 sites, 
and NF-gB site are marked. The bent arrow represents the start site of transcription upstream of the luciferase  reporter gene (LUC). Total luciferase 
activity (light units) from transfected THP-1 cells was measured and normalized for the amount of DNA uptake by using pRSVCAT as an internal 
control. The average fold induction of luciferase activity expressed by each plasmid in response to LPS in three independent experiments is shown 
with the standard deviation. 
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ciferase reporter gene in p19LUC (Fig.  1). Transcriptional 
activity of the TF promoter was quantified by measuring lu- 
ciferase activity expressed by transiently transfected human 
THP-1 monocytic cells. TF promoter constructs exhibited 
low promoter activity in unstimulated cells (Table 1), consis- 
tent with a low rate of transcription of the endogenous TF 
gene (30). 
To determine the approximate location of LREs within the 
5' flank of the TF gene, we analyzed luciferase activity ex- 
pressed by these plasmids in THP-1 cells stimulated with LPS. 
Plasmids could be divided into two classes, "high" or "low;' 
depending on the magnitude of the response to LPS (Fig. 1). 
The first class included nine plasmids,  pTF(-2106)LUC to 
pTF(-244)LUC, which all exhibited high levels of induc- 
tion averaging 7.6-fold. The second class averaged only 2.8- 
fold induction and included five plasmids, pTF(-194)LUC 
to pTF(-67)LUC.  Removal of DNA between  -194  and 
-68 did not significantly influence the level of LPS induc- 
tion, although the basal promoter activities associated with 
Table  1.  Luciferase  Activity Expressed by TF Promoter 
Plasmids in Unstimulated THP-I  Cells 
Luciferase 
activity 
Plasmid  (-LPS)  pRSVLUC 
pTF(-2106)LUC  2,884  11 
pTF(-948)LUC  4,868  18 
pTF(-383)LUC  4,735  18 
pTF(-363)LUC  3,884  14 
pTF(-333)LUC  5,452  20 
pTF(-321)LUC  4,186  16 
pTF(-306)LUC  5,509  20 
pTF(-278)LUC  4,507  17 
pTF(-244)LUC  5,413  20 
pTF(-194)LUC  4,379  16 
pTF(-153)LUC  3,249  12 
pTF(-lll)LUC  2,884  11 
pTF(-96)LUC  1,176  4 
pTF(-67)LUC  258  1 
pTF(-33)LUC  216  <1 
pTF(-21)LUC  215  <1 
pRSVLUC  26,951  - 
p19LUC  210  - 
Total luciferase activity for a typical experiment is shown as light units 
and also as a percentage of the level expressed by pRSVLUC, pRSVLUC 
and p19LUC were used as positive and negative controls, respectively. 
Transfection ef~dendes between various TF promoter plasmids were nor- 
malized using expression by pRSVCAT. 
pTF(- 96)LUC and pTF(-67)LUC were significantly reduced 
(Table 1). Finally, pTF(-33)LUC and pTF(-21)LUC were 
not transcriptionally active. 
These studies indicated the presence of at least one LRE 
within the TF promoter with a 5' boundary at approximately 
- 244. In addition, DNA sequences  between - 2106 and - 245 
did not appear to be required for LPS induction in these mono- 
cytic cells. Removal of DNA (-244 to -195) containing two 
AP-1 sites decreased the level of LPS induction of the TF pro- 
moter from high to low, suggesting that AP-1, or a related 
transcription factor, may be required to mediate full LPS in- 
duction of the TF promoter. 
Localization of the LRE frora tke TF Promoter.  To more 
accurately define the 5' and 3' boundaries of this putative LRE, 
we analyzed the ability of various DNA fragments from the 
TF promoter to confer LPS responsiveness to a heterologous 
promoter. A 106-bp DNA fragment from the human PAI-1 
gene (-31 to  +75), which includes the minimal transcrip- 
tional initiation information, was inserted upstream of the 
luciferase reporter gene to create pPAI-LUC (Fig. 2). Based 
on the data described above, we inserted a 167-bp fragment 
(-278 to -112) from the TF promoter upstream of the human 
PAI-1 promoter to create pTF(278/112)FAI-LUC (Fig. 2). This 
plasmid contained two AP-1  sites and an NF-rB  site  and 
directed a 6.3-fold induction of luciferase activity in THP-1 
cells exposed to LPS, indicating that the 167-bp fragment 
included at least one LILE. Smaller DNA fragments were 
subsequently analyzed to more precisely define the bound- 
aries of the LRE, and to ducidate the role of the AP-1 and 
NF-KB sites. The 133-bp fragment ofpTF(244/ll2)PAI-LUC 
and the 100-bp fragment ofpTF(227/128)PAI-LUC each con- 
tained all three sites and both exhibited an equivalent 8.5- 
fold induction. Deletion of a DNA segment containing the 
two AP-1 sites created pTF(207/112)PAI-LUC  and drastically 
reduced the level of induction to 3.2-fold. These data more 
accurately  defined the 5' boundary of this LRE to  -227. 
Furthermore, removal of DNA between -179 and -112 dis- 
rupted the NF-KB site in pTF(227/180)PAI-LUC and abol- 
ished LPS induction of luciferase activity.  These data indi- 
cate that one or both of the AP-1 sites together with the 
NF-rB site are required for ~  functional activity of the LRE. 
As a next step in the localization and identification of func- 
tional binding sites within this LRE, a 56-bp oligonucleo- 
tide (-227 to -172) was designed to include both AP-1 sites 
and the NF-rB site. This DNA was inserted upstream of the 
minimal  PAI-1  promoter  in  pTF(227/172)PAI-LUC  and 
directed an 11-fold induction of luciferase activity in tran- 
siently transfected THP-1 cells stimulated with LPS (Fig. 2). 
Therefore, the 56-bp region contains most, if not all, of the 
information necessary for binding transcription factors that 
mediate LPS induction of this LRE. Furthermore, a similar 
level of induction was observed when this 56-bp region of 
the TF promoter was inserted in the opposite orientation (data 
not shown). 
By dividing the 56-bp region into two subregions, we 
wished to determine if either the 5' subregion, designated 
region I (-227 to  -189),  or the Y  subregion, designated 
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Figure 2.  LPS induction of TF promoter plasmids from the heterologous promoter series. All plasmids in this series, including the control pPAI-LUC, 
contain  the minimal PAl-1 promoter (PAI-1) upstream of the luciferase reporter gene (LUC).  Restriction  endonuclease sites used to generate some 
of these plasmids are shown, pPAI-LUC expressed "~1,800 light units of luciferase activity in a typical experiment. Addition of DNA fragments from 
the TF promoter increased basal expression from the heterologous  promoter by an average of 3.6-fold,  which is comparable with levels associated with 
the wild-type TF promoter. Regions I and II of the LRE are shown together  with AP-1 and and NF-KB binding sites. The 3-bp substitution  in the 
NF-:cB site is indicated by the filled box. Total luciferase activity (light units) from transfected THP-1  cells were measured as described in Fig.  1 in 
three independent  experiments.  The RsaI site was introduced by site-directed mutagenesis  (25). 
region II (- 192 to - 172), could function independently. Cells 
transfected with pTF(227/189)PAI-LUC,  which contained re- 
gion I and included the two AP-1  sites,  did not exhibit a 
significant response to stimulation with LPS (Fig. 2). In con- 
trast, cells transfected with pTF(192/172)PAI-LUC, which 
contained region II and included the NF-KB site, exhibited 
a 9.5-fold induction of luciferase activity in response to LPS. 
However, it must be noted that the NF-KB site within the 
21-bp insert of this plasmid is removed from its normal con- 
text, and the observed high level induction compared with 
that  directed  by  the  larger  NF-KB-containing  plasmid, 
pTF(207/112)PAI-LUC  (see above), may reflect loss of a postu- 
lated  downstream binding  site(s)  for  negative  regulatory 
factors. Nevertheless, we examined the role of the NF-rB site 
within the 56-bp region.  A  3-bp substitution within the 
NF-KB site between -181 and -179 in pTFM1 (227/172)PAI- 
LUC abolished the ability of the 56-bp region to direct LPS 
induction of luciferase activity.  These data strongly demon- 
strate the requirement for the NF-KB site in the LPS induc- 
tion of the TF promoter. 
Mutagenesis of the LRE in the Wild-type TF Promoter.  To 
examine whether the L1LE identified using the heterologous 
promoter  is indeed valid for LPS induction of cells bearing 
the wild-type TF promoter, we mutated the two AP-1 sites 
and the NF-KB site within the LRE (-227 to  -172) either 
separately or in combination (Fig. 3). pTF(- 278)LUC was chosen 
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Figure 3.  LPS induction of TF promoter plasmids from the mutant series. The position of base pair substitutions in these various plasmids is indicated 
by filled boxes. Mutation of the AP-1 sites and the NF-KB site did not significantly reduce the basal levels of luciferase activity associated with the 
seven mutant plasmids, pTFM2(-278)LUC to pTFM8(-278)LUC.  Regions I and II of the LRE are shown together with AP-1 and NF-gB  binding 
sites. Total luciferase activity (light units) from transfected THP-1  cells were measured as described in Fig.  1 in four independent experiments.  The 
level of induction from the "low"  and "high" classes is indicated. 
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tained a fully functional LRE and directed a high level of 
induction (7.1-fold)  in response to LPS. It should be noted 
that complete disruption of this LRE would still be expected 
to yield a threefold induction in response to LPS. 
When compared to the induction levels associated  with 
the wild-type promoter in pTF(-278)LUC, mutation of the 
distal AP-1 site (-223 to  -217) in pTFM2(-278)LUC de- 
creased the level of the induction to 4.7-fold in THP-1 cells 
stimulated with LPS, whereas mutation of the proximal AP-1 
site (-210 to -204) in pTFM3(-278)LUC failed to decrease 
the level of induction (Fig. 3). Mutation of both AP-1 sites 
in  pTFM24(-278)LUC  decreased  the  induction  level  to 
fivefold.  Furthermore, mutation of two overlapping 10-bp 
regions in pTFMS(- 278)LUC and pTFM6( - 278)LUC, both 
of which disrupted the NF-xB site (-188 to -179) in region 
II, reduced induction levels to fourfold. Finally, when both 
AP-1 sites and the NF-xB site were mutated simultaneously, 
the levels of LPS induction associated  with either pTFM7- 
(-278)LUC or pTFM8(-278)LUC were further reduced to 
only 3.2-fold. This low level of induction is comparable with 
that exhibited by pTF(- 111)LUC, in which the complete up- 
stream LRE had been deleted. These data indicate that both 
the NF-KB site and the distal AP-1 site are required to mediate 
full LPS induction of the wild-type TF promoter. 
Table  2.  Oligonucleotides Used in This Study 
Oligonucleotides 
Analysis of Transcription Factors That Bind to the LRE from 
the TF Promot~  To identify transcription factors that bind 
to the LKE from the TF promoter, we performed EMSAs. 
First, we analyzed the ability of NF-xB, or a related protein, 
to bind to region II (-192 to  -172) of the LKE. Nuclear 
extracts, prepared from either THP-1 cells exposed to LPS 
for 45  rain or control cells, were incubated with M19/20 
(Table 2),  a double-stranded 21-bp oligonucleotide spanning 
the NF-xB site within the TF promoter. A  protein-DNA 
complex was observed  using LPS-induced nuclear extracts 
but not using control extracts (Fig.  4). This protein-DNA 
complex was specifically competed by a consensus NF-tcB site 
(Table 2), but not by a 100 x  molar excess of either M23/24 
(Table 2), an oligonudeotide containing a 3-bp substitution 
in the NF-xB site from the TF promoter, or an irrelevant 
oligonucleotide. A  similar complex was observed when an 
oligonucleotide containing a consensus NF-t~B (Table 2) was 
incubated with an LPS-induced nuclear extract (Fig. 4). There- 
fore, it appears that NF-t~B, or a dosely related protein, binds 
to region II of the LRE. 
Second,  we investigated whether a member of the AP-1 
family could bind to region I (- 227 to  -  189) of the LRE. 
Nuclear extracts were incubated with M14/15 (Table 2),  a 
double-stranded 35-bp oligonucleotide from the TF promoter 
that included both AP-1 sites. A specific protein-DNA corn- 
M 14 
M  15 
M  19 
M 20 
M 23 
M 24 
M  17 
M  18 
AP-1 
NF-xB 
-227  -193 
5'  -CGGTTGAATCACTGGGGTGAGTCATCCCTTGCAGG-3' 
3'  -GCCAACTTAGTGACCCCACTCAGTAGGGAACGTCCCAGG-5' 
-192  -172 
5'  -GTCCCGGAGTTTCCTACCGGG-3' 
3'  -GCCTCAAAGGATGGCCC-5' 
-192  -172 
5'  -GTCCCGGAGTTIGATACCGGG-3' 
3'  -GCCTCAATCTATGGCCC-5' 
-204  -175 
5'  -ATCCCTTGCACCTCGAGGAAGTTTCCTACC-3' 
-195  -166 
5'  -AGGGTCCCGGCCTCGAGGAACGGGAGGAGG-3 
ConsensusS'-GAGCCGCAAGTGACTCAGCGCGGGGCGTGTGCAGG-3' 
Consensus5'-CAGAGGGGACTTTCCGAGA-3' 
Binding sites for AP-1 and NF-KB are underlined. Numbering  of the 5' ~  3' DNA strand is relative  to the transcription  start site of the TF promoter 
at + 1. M14/15 represents region I and was used to examine  AP-1 binding  in EMSA; plasmids  containing  this region  were used to assess the function- 
al activity  of the AP-1 sites in THP-1 cells. M19/20 represents region II and was used to study NF-xB binding  and functional  activity  of this region. 
M23/24 contains  a 3-bp substitution  in the NF-gB  binding  rite. The oligonudeotides  M17 and 18 were used  for site-directed  mutagenesis.  Oligonucleotides 
containing  consensus  binding  sites for either  NF-IcB or AP-1 were used as positive  controls in the EMSAs. The oligonudeotide  containing  a consensus 
NF-KB binding site was derived from the mouse Ig x enhancer. The AP-1 consensus oligonuc!eotide  was kindly provided by Dr. K. Kaushansky 
and was derived from the human metallothionein-II^  enhancer. 
" Base pair substitutions differing  from that of the wild-type  TF promoter. 
1521  Mackman et al. Figure 4.  Electrophoretic mobility shift assay of NF-KB binding. Nu- 
clear  extracts  were prepared from either control THP-1  cells or LPS- 
stimuhted cells and incubated with a 21-bp oligonucleotide, M19/20 (Table 
2). 50,000 counts of M19/20 were incubated with 10/~g of nuclear ex- 
tract in the presence of 6/zg poly(dI.dC). Lane 1, M19/20 with control 
extract; lane 2, M19/20 with LPS-indueed  extract. Lanes 3-11  contain 
M19/20 with LPS-induced extract and various amounts of unlabehd com- 
petitors: lanes 3, 4,  and 5 contain 25x,  50x,  and 100x  molar excess, 
respectively, of M19/20; lanes 6, 7, and 8 contain 25x, 50x, and 100x 
molar excess, respectively, of M23/24,  a mutated NF-KB site (Table 2); 
lanes 9 and 10 contain 25x  and 50x  molar excess, respectively, of the 
NF-sB consensus oligonudeotide. Lane I1 contains a 100x  molar excess 
of an irrelevant oligonucleotide, M14/15.  Lane 12 contains 10,000 counts 
of the NF-xB consensus oligonudeotide incubated with 7.8 #g of" LPS- 
stimulated extract. The position of the protein-DNA complex corresponding 
to NF-KB binding is indicated with a filled triangle, whereas the free oli- 
gonucleotide is marked with an open triangle. The band below the NF-KB 
complex appears to represent  a nonspecific complex. Lanes 1-11 were ex- 
posed for 48 h, whereas  lane 12 was exposed  for 16 h  at  -80~  with 
an intensifier  screen. 
Figure 5.  Electrophoretic mobility shift assay of AP-1 binding. Nuclear 
extracts were prepared from either control THP-1 cells or LPS-stimulated 
cells and incubated with a 35-bp double-stranded  oligonucleotide,  M14/15 
(Table 2). 50,000 counts of M14/15  were incubated with 1.68/zg of nu- 
clear extract in the presence of 6 #g poly (dl.dC). Lane 1, M14/15  with 
control extract; lane 2, M14/15 with LPS-induced extract. Lanes 3-7 con- 
tain M14/15 with LPS-induced extract and various amounts of unlabded 
competitors: lanes 3, 4, and 5 contain 25x, 50x, and 100x  molar excess, 
respectively, of M14/15; lanes 6 and 7 contain 25x  and 50x  molar excess, 
respectively, of the AP-1 consensus oligonucleotide (Table 2). Lane 8 con- 
tains 100x  molar excess of an irrelevant oligonucleotide, M19/20 (Table 
2). lanes 9 and 10 contain 50,000 counts of the labeled AP-1 consensus 
oligonucleotide incubated with control and LPS-indueed extract, respec- 
tively. The position of the protein-DNA complex proposed to contain 
AP-1 is indicated with a failed triangle, whereas  the free oligonudeotide 
is marked with an open triangle. The autoradiogram was exposed for 16 h 
at  -80~  with an intensifier  screen. 
plex  was  observed  only  when  nuclear  extract  from  LPS- 
stimulated cells was used (Fig. 5). This complex was specifically 
competed by an AP-1 consensus oligonudeotide (Table 2) but 
not by a 100x  molar excess of an irrelevant oligonucleotide. 
Incubation of the AP-1 consensus oligonucleotide with the 
LPSqnduced nuclear extract produced a similar complex (Fig. 
5). These results suggest that LPS stimulation of THP-1 cells 
activates  AP-1, or an AP-l-like protein,  and allows binding 
to  the LR.E of the TF  promoter. 
Discussion 
LPS is a  potent  pathogenic  molecule  in  higher  primates 
that is implicated in several disease states including septic shock 
(31). Inhibition of TF activity in vivo by a mAb has provided 
therapeutic benefit in a baboon  model of E.  coli bacteremia 
(9).  We have previously  shown  that  induced  expression  of 
TF in monocytes in response to LPS is controlled primarily 
at the level of transcription (6). Therefore, in the present study 
we have investigated the regulation of TF gene transcription 
in cells of monocytic lineage. We have identified a 56-bp LRE 
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Figure 6.  Conservation  of the LPS 
response element from the human and 
mouse TF promoters.  Binding sites for 
distal and proximal AP-1 sites and the 
NF-KB site are shown in regions I and 
II of the LRE. Numbering is from the 
start  site of transcription  at  + 1 (52). 
within the human TF promoter that conferred LPS respon- 
siveness to a heterologous promoter and functioned in a po- 
sition and orientation-independent manner. The LRE was 
composed of two subregions,  region I and region II (Fig. 
6), which bind AP-1- and NF-gB-like proteins. 
Deletion of region I or mutation of the distal AP-1 site 
within this region both decreased the level of LPS induction 
and indicated that this distal AP-1 site was required for full 
functional activity of the LIkE in situ in the TF promoter. 
The proximal AP-1 site within region I appeared to have no 
major role in LPS induction, although the dose tandem ar- 
rangement of these two AP-1 sites may suggest functional 
cooperativity. An AP-l-like transcription factor was present 
in LPS-induced nuclear extracts of THP-1 cells that s1~:ifically 
bound to region 1. The AP-1 family is involved in the tran- 
scriptional regulation of several inducible genes such as col- 
lagenase (32) and IL-2 (33). 
Region II contains an NF-KB site that is essential for full 
functional activity of the LRE. Mutation of this NF-KB site 
abolished the ability of the 56-bp LRE to direct LPS induc- 
tion of luciferase activity. Moreover, a 21-bp DNA fragment 
containing this site conferred LPS responsiveness to a hater- 
ologous promoter. A specific  protein-DNA complex was ob- 
served in EMSA when this 21-bp oligonucleotide was in- 
cubated with nuclear extract from LPS-induced THP-1 cells, 
which was competed by a consensus NF-KB site. A recent 
study (34) is consistent with our data revealing that LPS stim- 
ulation of THP-1 cells activates NF-~B. Thus, engagement 
of this binding site in region II by NF-r,B appears to be neces- 
sary to mediate full transcriptional induction of the TF pro- 
moter in response to LPS. NF-gB has been established as a 
member of the tel family of proteins,  all of which display 
cytosolic-nuclear translocation  (35, 36). 
In the wild-type TF promoter the functional activity of 
the NF-KB site appears to be modulated by the binding of 
regulatory proteins to flanking or overlapping  DNA sequences. 
We speculate that the NF-KB site may be negatively regu- 
lated by the binding of proteins  to 3' or overlapping sites, 
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similar to the binding of a family of constitutively expressed 
C/EBP-like proteins to the NF-KB site  in the angiotensinogen 
gene (37). In contrast, the presence of a protein bound to 
an upstream AP-1 site may stabilize the binding of NF-KB 
via protein-protdn interactions. We hypothesize that the LRE 
is a combinatorial unit that requires the presence of both the 
NF-gB site, which may act as the "core," and the distal AP-1 
site. We propose that assembly of a transcriptional enhandng 
complex involves cooperative interactions between proteins 
of the NF-gB and AP-1 families. It is of  note that DNA binding 
of  both of these proteins is regulated by phosphorylation (38, 
39). The exact identity of the transcription  factors that bind 
to this LRE will require further characterization using purified 
proteins  and specific antibodies. 
Isolation of the complete murine TF gene, including 5' 
flanking sequences, has allowed identification  of conserved 
regions  of these two promoters that may serve regulatory 
roles. The overall sequence identity of regions between - 300 
and  +1 was 64% (data not shown).  In contrast, the 56-bp 
LRE exhibited 90% sequence identity between murine and 
human sequences with 100% conservation of the two AP-1 
sites and the NF-KB site (Fig. 6). This supports our conclu- 
sion that the 56-bp region is a major regulatory element in 
the TF promoter. 
In this study, we have shown that NF-gB is activated in 
THP-1 monocytic cells. This transcription  factor has been 
implicated in the regulation of genes involved in inflamma- 
tion, including IL-6, TNF, and Ib8. For instance, the NF-KB 
site within the human II.-6 promoter is required to mediate 
both LPS inducibility of the Ib6 gene in U937 monocytic 
cells (40) and the response to the cytokines IL-1 and TNF 
(41). LPS induction of the murine TNF gene involves several 
regions containing four NF-KB sites (42) that were shown 
to bind NF-KB (43). NF-KB- and NF-IL6-1ike  proteins bound 
to two regions of the IL-8 promoter that conferred respon- 
siveness to ID1 and TNF (44). This 24-bp region of the Ib8 
promoter contains an NF-IL6 site (45) immediately upstream 
of an NF-KB site and shows a similar organization to that of the distal portion of the 56-bp LRE of the TF promoter. 
In contrast,  other reports concluded that the NF-KB site is 
not a major contributory element for induction of the II.-6 
gene (46). In fact, I1.-1 responsiveness of the Ib6 promoter 
was found to be mediated by a separate NF-IL6 binding ele- 
ment (47). A recent study on the human TNF promoter con- 
duded that three NF-KB sites were not involved in LPS in- 
duction, despite NF-KB binding to these sites (48). Moreover, 
activation of NF-KB alone in LPS-desensitized Mono-Mac-6 
monocytic cells was not sufficient to induce transcription of 
the TNF gene (49). These discrepancies may reflect difficul- 
ties in defining combinatorial response elements. In addition, 
NF-KB-binding activity may not correspond to a single poly- 
peptide but rather to a family of DNA-binding proteins (50), 
some of which may be modulated by other proteins to bind 
to lower affinity KB-related  sequences (51). 
This study using THP-1 monocytic cells has identified a 
56-bp LRE that  is composed of two distinct  regions  that 
are required to mediate LPS induction of the TF gene. This 
combinatorial dement includes both AP-1 and NF-tcB sites 
and may serve as a prototypic example for regulated assembly 
of transcription  factor complexes. NF-KB sites could repre- 
sent common c/s-acting elements that  are required for the 
activation  of genes  encoding  inflammatory  mediators.  As 
postulated from the present studies, the context of NF-KB 
sites within these various promoters appears to dictate their 
regulation.  We propose that NF-KB sites act synergistically 
with other binding sites to assemble two or more transcrip- 
tion factors in a supramolecular complex to mediate full tran- 
scriptional  activation. 
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